Champix sales soar

Published: 2007-06-05 06:57:00

Updated: 2007-06-05 06:57:00

Pfizer Korea said on May 31 that its sales of Champix tablets (varenicline tartrate), a medication for smoking cessation, amounted to around 2.0 billion in just one week after it was launched on May 21.

Champix is a newly released anti-smoking pill that is nicotine-free and approved by the U.S...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK